←Back to Expert Scholars
Translational Medicine / 转化医学TIL Therapy, Thoracic Oncology
Ali Alrajhi
MD
🏢King Faisal Specialist Hospital and Research Centre🌐Saudi Arabia
Consultant Medical Oncologist
20
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ali Alrajhi develops cell therapy and TIL access programs for thoracic cancers in the Middle East. He collaborates internationally to bring TIL protocols to patients with advanced NSCLC. His regional leadership expands access to advanced immunotherapy.
Share:
🧪Research Fields 研究领域
TIL therapy
lung cancer
regional programs
immunotherapy
cell therapy access
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ali Alrajhi 的研究动态
Follow Ali Alrajhi's research updates
留下邮箱，当我们发布与 Ali Alrajhi（King Faisal Specialist Hospital and Research Centre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment